S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
EXPLAINER: What's the effect of Russian oil price cap, ban?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
EXPLAINER: What's the effect of Russian oil price cap, ban?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
EXPLAINER: What's the effect of Russian oil price cap, ban?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
EXPLAINER: What's the effect of Russian oil price cap, ban?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal

ICU Medical - ICUI Stock Forecast, Price & News

$161.44
-1.26 (-0.77%)
(As of 12/2/2022 12:00 AM ET)
Add
Compare
Today's Range
$160.45
$163.29
50-Day Range
$136.41
$165.56
52-Week Range
$128.90
$251.73
Volume
87,238 shs
Average Volume
178,925 shs
Market Capitalization
$3.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$195.00

ICU Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
20.8% Upside
$195.00 Price Target
Short Interest
Bearish
6.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.47
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$52,039 Sold Last Quarter
Proj. Earnings Growth
12.74%
From $5.18 to $5.84 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.99 out of 5 stars

Medical Sector

676th out of 1,034 stocks

Surgical & Medical Instruments Industry

73rd out of 104 stocks

ICUI stock logo

About ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICUI Stock News Headlines

U.S. FDA warns of tracheostomy tube shortage
UPDATE 1-U.S. FDA warns of tracheostomy tube shortage
FDA Signals Shortage Of ICU Medical's Tracheostomy Tubes
ICUI ICU Medical, Inc.
Expert Ratings for ICU Medical
ICU Medical: Q2 Earnings Insights
ICU Medical Announces Second Quarter 2022 Results
ICU Medical PT Lowered to $230 at KeyBanc
See More Headlines
Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICUI Company Calendar

Last Earnings
11/03/2021
Today
12/03/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
8,500
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$195.00
High Stock Price Forecast
$200.00
Low Stock Price Forecast
$190.00
Forecasted Upside/Downside
+20.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$103.14 million
Pretax Margin
-3.41%

Debt

Sales & Book Value

Annual Sales
$1.32 billion
Cash Flow
$10.46 per share
Book Value
$83.93 per share

Miscellaneous

Free Float
22,231,000
Market Cap
$3.87 billion
Optionable
Optionable
Beta
0.54

Social Links


Key Executives

  • Mr. Vivek JainMr. Vivek Jain (Age 50)
    CEO & Chairman
    Comp: $1.31M
  • Mr. Brian Michael Bonnell (Age 48)
    CFO & Treasurer
    Comp: $645.5k
  • Mr. Christian B. Voigtlander (Age 53)
    Chief Operating Officer
    Comp: $685.5k
  • Ms. Virginia Ruth SanzoneMs. Virginia Ruth Sanzone (Age 47)
    Corp. VP, Gen. Counsel, Sec. & Compliance Officer
    Comp: $523.5k













ICUI Stock - Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICUI shares.
View ICUI analyst ratings
or view top-rated stocks.

What is ICU Medical's stock price forecast for 2023?

2 Wall Street research analysts have issued 1-year price objectives for ICU Medical's shares. Their ICUI share price forecasts range from $190.00 to $200.00. On average, they predict the company's stock price to reach $195.00 in the next twelve months. This suggests a possible upside of 20.8% from the stock's current price.
View analysts price targets for ICUI
or view top-rated stocks among Wall Street analysts.

How have ICUI shares performed in 2022?

ICU Medical's stock was trading at $237.34 at the start of the year. Since then, ICUI stock has decreased by 32.0% and is now trading at $161.44.
View the best growth stocks for 2022 here
.

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our ICUI earnings forecast
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) released its quarterly earnings results on Wednesday, November, 3rd. The medical instruments supplier reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.50. The medical instruments supplier earned $336.06 million during the quarter, compared to the consensus estimate of $314.20 million. ICU Medical had a negative net margin of 1.90% and a positive trailing twelve-month return on equity of 6.51%. During the same quarter in the previous year, the business posted $1.61 EPS.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical issued an update on its FY 2022 earnings guidance on Monday, November, 21st. The company provided earnings per share guidance of $6.20-$6.80 for the period, compared to the consensus earnings per share estimate of $6.52. The company issued revenue guidance of -.

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.60%), BlackRock Inc. (7.22%), State Street Corp (2.39%), Neuberger Berman Group LLC (1.58%), Segall Bryant & Hamill LLC (1.58%) and River Road Asset Management LLC (1.20%). Insiders that own company stock include Elisha W Finney, George A Lopez, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends
.

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $161.44.

How much money does ICU Medical make?

ICU Medical (NASDAQ:ICUI) has a market capitalization of $3.87 billion and generates $1.32 billion in revenue each year. The medical instruments supplier earns $103.14 million in net income (profit) each year or ($1.56) on an earnings per share basis.

How many employees does ICU Medical have?

The company employs 8,500 workers across the globe.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The official website for the company is www.icumed.com. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at ir@icumed.com, or via fax at 949-366-8368.

This page (NASDAQ:ICUI) was last updated on 12/3/2022 by MarketBeat.com Staff